• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VAP
Click for more information
0.46% $75.07

VANGUARD AUSTRALIAN PROPERTY SECURITIES INDEX ETF

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VAP
Ann: Outstanding ETF Securities and Fund Flows Announcement 		04/10/24 0 98
04/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  98 
VAP
Ann: Distribution Tax Estimates 		02/10/24 0 73
02/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  73 
VAP
Ann: DRP Issue Price Announcement for the period ended 30 Sep 24 		02/10/24 0 70
02/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  70 
VAP
Ann: Final Distribution Announcement 		02/10/24 0 81
02/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  81 
VAP
Ann: Updated Estimated Distribution Announcement 		01/10/24 0 88
01/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  88 
VAP
Ann: Updated Estimated Distribution Announcement 		30/09/24 0 87
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  87 
VAP
Ann: Updated Product Disclosure Statement 		30/09/24 0 78
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  78 
VAP
Ann: Estimated Distribution Announcement 		26/09/24 0 120
26/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 

See All Discussions arrow Created with Sketch.

Timeline

Outstanding ETF Securities and Fund Flows Announcement
04 Oct 13:51
 
Distribution Tax Estimates
02 Oct 15:41
 
DRP Issue Price Announcement for the period ended 30 Sep 24
02 Oct 15:40
 
Final Distribution Announcement
02 Oct 08:21
 
Updated Estimated Distribution Announcement
01 Oct 08:40
 
Updated Estimated Distribution Announcement
30 Sep 09:10
 
View More arrow Created with Sketch.

Featured News

NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children with Phelan-McDermid syndrome.
Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program Arika Resources Ltd has received commitments from investors in support of a Placement worth $3.2 million to support gold exploration in WA
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.

Featured News

NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.